Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRNB4 | P30926 | 1/20 | 0.39 |
| ▸ | CHRNA3 | P32297 | 1/20 | 0.39 |
| ▸ | RXRB | P28702 | 7/20 | 0.38 |
| ▸ | RXRA | P19793 | 6/20 | 0.38 |
| ▸ | RXRG | P48443 | 3/20 | 0.38 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.37 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.37 |
| ▸ | PGR | P06401 | 2/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.36 |
| ▸ | GAA | P10253 | 1/20 | 0.36 |
| ▸ | MAPT | P10636 | 1/20 | 0.36 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.33 |
| ▸ | S1PR3 | Q99500 | 1/20 | 0.33 |
| ▸ | ASIC3 | Q9UHC3 | 1/20 | 0.31 |
| ▸ | POLB | P06746 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27018947 | 1.00 | CHRNB4 (0.39) | CHRNB4CHRNA3RXRBRXRARXRG | |
| SCHEMBL29416703 | 0.85 | GABRA1 (0.44) | RXRBRXRARXRGGABRA1GABRB2 | |
| SCHEMBL28375569 | 0.85 | GABRA1 (0.44) | RXRBRXRARXRGGABRA1GABRB2 | |
| SCHEMBL23915436 | 0.85 | GABRA1 (0.44) | RXRBRXRARXRGGABRA1GABRB2 | |
| SCHEMBL18537286 | 0.85 | GABRA1 (0.44) | RXRBRXRARXRGGABRA1GABRB2 | |
| SCHEMBL29436334 | 0.83 | RXRB (0.42) | RXRBRXRARXRGGABRA1GABRB2 | |
| SCHEMBL30472433 | 0.83 | GABRA1 (0.37) | CHRNB4CHRNA3GABRA1GABRB2KDM4E | |
| SCHEMBL23909387 | 0.83 | RXRB (0.42) | RXRBRXRARXRGGABRA1GABRB2 | |
| SCHEMBL1725233 | 0.83 | GABRA1 (0.37) | CHRNB4CHRNA3GABRA1GABRB2KDM4E | |
| SCHEMBL31071024 | 0.83 | RXRB (0.41) | RXRBRXRARXRGGABRA1GABRB2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117998879-A | Heterocyclic compound, and light-emitting device, electronic device, and electronic apparatus including the same | 三星显示有限公司 | 2024-05-07 | — | — | CN | disclosed |
| CN-117903182-A | Light emitting device and polycyclic compound for use therein | 三星显示有限公司 | 2024-04-19 | — | — | CN | disclosed |
| CN-117729789-A | Light-emitting element | 三星显示有限公司 | 2024-03-19 | — | — | CN | disclosed |
| US-20240023439-A1 | LIGHT EMITTING DEVICE AND POLYCYCLIC COMPOUND FOR THE SAME | SAMSUNG DISPLAY CO., LTD. (KR) | 2024-01-18 | — | — | US | disclosed |
| CN-117327109-A | Light emitting device and polycyclic compound for use therein | 三星显示有限公司 | 2024-01-02 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240023439-A1 | LIGHT EMITTING DEVICE AND POLYCYCLIC COMPOUND FOR THE SAME | LAGE3, TMEM109, ESR1 | CHRNB4 1778/4885CHRNA3 1087/4885RXRB 4656/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.